Food News and Research

RSS

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Right-wing radio host Rush Limbaugh once vowed to flee to Costa Rica if President Barack Obama's health care reforms took effect. Limbaugh might have overlooked a couple of critical details: Costa Rica's respected universal healthcare system is highly socialized. It's also on the verge of going broke. ... Costa Rica's broad coverage ranked better than most of the Americas, including the United States, in a 2000 World Health Organization index.

26 Aug 2011

Firazyr receives FDA approval for treatment of HAE acute attacks

The U.S. Food and Drug Administration today approved Firazyr (icatibant) Injection for the treatment of acute attacks of a rare condition called hereditary angioedema (HAE) in people ages 18 years and older.

26 Aug 2011

GCC hormone receptor may also help fight obesity

The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest pandemics: obesity.

26 Aug 2011

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.

26 Aug 2011

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for FIRAZYR for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

26 Aug 2011

Antidepressant alert – Citalopram associated to heart rhythm disturbances

Antidepressant citalopram (Celexa, Forest Laboratories) should not be used in doses higher than 40 mg per day because of concerns that it can cause potentially fatal changes in heart rhythm, the US Food and Drug Administration (FDA) warns.

25 Aug 2011

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.

25 Aug 2011

KFC withdraws toys from kid’s food

Australian fast-food chain KFC has promised to remove the toys from its children's meals. This has been cheered by anti-obesity lobby groups.

25 Aug 2011

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.

25 Aug 2011

MDxHealth first half 2011 commercial revenues increase 19%

MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results.

25 Aug 2011

Removal of OTC drugs for toddlers from the market reduces therapeutic errors

A new study by researchers at the University of Maryland has revealed a 46 percent drop in reported errors after drugmakers in October 2007 removed from the market a number of over-the-counter cough and cold medications labeled for children under the age of 2.

25 Aug 2011

AHF shares The Lancet's concerns over use of Gilead's Truvada as HIV prevention pill

Today AIDS Healthcare Foundation (AHF) commented on an editorial published in the September 2011 issue of The Lancet Infectious Diseases that raises concerns about the use of the HIV treatment drug Truvada, manufactured by Gilead Sciences Inc., as an HIV prevention pill or pre-exposure prophylaxis (PrEP), agreeing with the publication's public health concerns.

25 Aug 2011

Insight into how bacterial toxins cause human diseases may help improve treatment

A better understanding of how bacterial toxins cause common human diseases may lead to their improved treatment and prevention according to a paper just published by Irish and US scientists in Nature Reviews Microbiology.

25 Aug 2011

Foreign drug manufacturing, testing raise regulatory and ethical concerns

JAMA discusses "a recent report from the Pew Health Group about the growing risks of substandard and counterfeit medications resulting from the increasing overseas production of pharmaceuticals and their ingredients."

25 Aug 2011

U.N. summit on NCDs 'is a battleground' of private versus public interests

David Stuckler of the University of Cambridge, Sanjay Basu of the University of California, San Francisco, and Martin McKee of the London School of Hygiene and Tropical Medicine, write in a BMJ commentary that misconceptions and fallacies "have led to serious under-budgeting for non-communicable diseases".

25 Aug 2011

Crime and violence overshadowing malnutrition in Guatemalan presidential campaign

"Malnutrition, one of the leading killers of children under five in the Central American nation of Guatemala, is receiving scant attention on the campaign trail" ahead of the country's presidential elections scheduled for September, AlertNet reports.

25 Aug 2011

Some fear industry interests are stalling negotiations on U.N. NCD summit, BMJ reports

"In the run up to the U.N. summit on non-communicable diseases (NCDs), there are fears that industry interests might be trumping evidence-based public health interventions," BMJ reports.

25 Aug 2011

IRIN reports on HIV-positive Kenyans' struggle to reach food aid

IRIN reports on the difficulties some people living with HIV in Kenya face in accessing food. "Partly because of a prolonged dry spell, some 3.6 million Kenyans need emergency food assistance," and, while there is food aid available in Kenya, poor roads prevent the aid from reaching some villages, according to IRIN.

25 Aug 2011

ADA's 2011 food and nutrition conference to be held in San Diego

The world's largest annual meeting of food and nutrition professionals, the American Dietetic Association's 2011 Food & Nutrition Conference & Expo, will be held September 24 to 27 in San Diego, Calif.

25 Aug 2011

Food News and Research

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Firazyr receives FDA approval for treatment of HAE acute attacks

GCC hormone receptor may also help fight obesity

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Antidepressant alert – Citalopram associated to heart rhythm disturbances

Allergan gets FDA nod for use of Botox in urinary incontinence

KFC withdraws toys from kid’s food

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

MDxHealth first half 2011 commercial revenues increase 19%

Removal of OTC drugs for toddlers from the market reduces therapeutic errors

AHF shares The Lancet's concerns over use of Gilead's Truvada as HIV prevention pill

Insight into how bacterial toxins cause human diseases may help improve treatment

Foreign drug manufacturing, testing raise regulatory and ethical concerns

U.N. summit on NCDs 'is a battleground' of private versus public interests

Crime and violence overshadowing malnutrition in Guatemalan presidential campaign

Some fear industry interests are stalling negotiations on U.N. NCD summit, BMJ reports

IRIN reports on HIV-positive Kenyans' struggle to reach food aid

ADA's 2011 food and nutrition conference to be held in San Diego

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News